PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
May 30, 2026Journal of Clinical Oncology

Clinical profile and treatment outcomes of lymphoma patients: A retrospective cohort study.

View Full Paper
Ask AI
Bookmark
Share

Authors

NVNiveditha VasagiriRDRaghunadharao DigumartiCPChaitanya Krishna Puligundla

Discussion

Loading...

Member takes

Overview

Retrospective cohort study evaluates treatment responses and survival in lymphoma patients, suggesting challenges in low-resource settings.

Key Points

  • This study aims to assess the clinical characteristics, treatment responses, and outcomes of lymphoma patients in a real-world setting.
  • Retrospective cohort study including 450 patients diagnosed with lymphoma from January 2019 to December 2025.
  • Histological subtypes analyzed include Hodgkin lymphoma and various non-Hodgkin lymphoma types.
  • Treatment responses were assessed using clinical and radiological criteria.
  • Overall survival rate until December 2025 is 70%, with Hodgkin lymphoma showing an 82% survival rate.
  • 19% treatment default rate, affecting overall patient outcomes.
  • 17% relapse rate, with 60% of relapse patients alive due to effective salvage regimens.

Cite This Study

Vasagiri et al. (2026) studied this question.

synapsesocial.com/papers/6a1a814b0307b7850943335fhttps://doi.org/10.1200/jco.2026.44.16_suppl.e19100
View Full Paper
Ask AI
Bookmark
Share